Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical ...

Successful meeting with FDA enables advancement into pivotal development with Privosegtor in Acute Optic Neuritis (AON) and Non-arteritic ...

Axon stock is up more than 3,000% over the last decade. The company has built a unique business in law enforcement tech. The business is still growing briskly and expanding into new technologies. 10 ...

Fidelity Investments, an investment management company, recently released its “Fidelity Growth Strategies Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The ...

Indeed, after Scottsdale City Council dodged – for the time being, at least – filing a lawsuit, former Councilman Bob Littlefield may be the last hope for those wanting to stop Axon plans to build ...

Axon Enterprise, a publicly traded company that sells Tasers, body cameras and other products, reportedly is in talks to buy Prepared, a six-year-old supplier of emergency dispatch technology that ...

Abstract: The optic nerve plays a critical role in visual information processing by relaying signals from the retina to the brain. Diseases affecting the optic nerve, such as glaucoma, can severely ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Mid-cap ...

A former Senior Publishing Editor on the Dow Jones Newswires team at The Wall Street Journal, Aaron earned a Bachelor's degree in Economics from the University of Michigan and a Master's in Journalism ...

Axon Enterprise, Inc. (NASDAQ:AXON) shares are climbing after the company released its second-quarter results after Monday's closing bell. Here's a look at the key figures from the quarter. The ...